In response to: The validity of 18F-GE180 as a TSPO imaging agent.

Albert, N. L.; Unterrainer, M.; Brendel, M.; Kaiser, L.; Zweckstetter, M.; Cumming, P.; Bartenstein, P.

doi:10.1007/s00259-019-04294-8

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

In response to: The validity of ¹⁸F-GE180 as a TSPO imaging agent.

MPS-Authors

/persons/resource/persons16093

Zweckstetter, M.
Research Group of Protein Structure Determination using NMR, MPI for biophysical chemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Albert, N. L., Unterrainer, M., Brendel, M., Kaiser, L., Zweckstetter, M., Cumming, P., et al. (2019). In response to: The validity of ¹⁸F-GE180 as a TSPO imaging agent. European Journal of Nuclear Medicine and Molecular Imaging, 46(6), 1208-1211. doi:10.1007/s00259-019-04294-8.

Cite as: https://hdl.handle.net/21.11116/0000-0003-182E-0

Abstract

There is no abstract available